Environment Social Governance - ESG
The year 2024 marked an important milestone for Swixx Biopharma. As we celebrated our 10th anniversary, we also introduced our ESG framework, developed through extensive stakeholder engagement. The framework reflects our responsible, compliant, sustainable, and ethical approach to business and defines five ESG building blocks aligned with the UN Sustainable Development Goals:
- Put People First – promoting collaboration, well-being, safety, diversity, inclusion, and equity in the workplace.
- Ensure Access to Medicines – ensuring reliable supply of innovative therapies and diagnostics, expanding equitable access to care.
- Strengthen Community Partnerships – empowering patient organizations and collaborating with stakeholders to improve health outcomes, particularly among vulnerable populations.
- Preserve the Environment – implementing sustainable practices, responsible waste management, and reducing our environmental footprint.
- Foster Sustainable Corporate Governance – reinforcing our culture of compliance while applying the highest standards of governance and ethics.
Building on this foundation, in 2025 we are proud to publish our first comprehensive ESG Report for 2024, which translates our commitments into concrete KPIs and demonstrates measurable progress. This report reflects not only what we have achieved but also our vision for the future: creating lasting value for patients, employees, communities, and the environment.
2024 ESG Highlights
- 100% of employees completed initial HSE training, strengthening workplace safety and awareness.
- All Swixx warehouses now use certified waste service providers, reinforcing environmental stewardship.
- 4,427 diagnostic tests were performed through our rare disease program, expanding access to vital care.
- Our Swixx Patient Academy pilot launched in two countries, empowering patient organizations and communities.
- Swixx maintained ISO 37001 certification for Anti-Bribery Management System, underscoring our ethical standards.
Our ESG Journey
At Swixx Biopharma, sustainability is not a box to check but a continuous journey. The ESG framework provides the vision and direction, and our first ESG report demonstrates our progress with clarity and accountability.
We are guided by the belief that responsible business and lasting impact go hand in hand — and we will continue to improve lives ethically and sustainably, with unwavering dedication. Conscious of global efforts to integrate ESG into our business, we are dedicated to making a positive impact for our partners, patients, and communities.
ESG Strategy Framework (0.461 MB)
ESG Report 2024 (2.175 MB) 
